or Try an Advanced Search...

    Technical Analysis for LEXX - Lexaria Bioscience Corp.

    Grade Last Price % Change Price Change
    F 2.15 -2.27% -0.05
    LEXX closed up 1.38 percent on Wednesday, November 20, 2024, on 85 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical LEXX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.27%
    NR7 Range Contraction -2.27%
    Earnings Movers Other -2.27%
    Wide Bands Range Expansion -2.27%
    Up 3 Days in a Row Strength -2.27%
    MACD Bullish Signal Line Cross Bullish -0.92%
    Earnings Movers Other -0.92%
    Wide Bands Range Expansion -0.92%
    Oversold Stochastic Weakness -0.92%
    Stochastic Buy Signal Bullish 2.87%
    Older End-of-Day Signals for LEXX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 7 minutes ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry 7 minutes ago
    Fell Below Previous Day's Low 7 minutes ago
    Down 2 % 7 minutes ago
    Down 1% 7 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    LEXX Chart by TradingView
    Basic chart:

    Profile

    Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.
    Classification
    Sector: Consumer Defensive
    Industry: Packaged Foods
    Keywords: Health Sciences Pharmacy Psychoactive Drugs Drug Delivery Smoking Nutraceutical Nicotine Anxiolytics

    Is LEXX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
    Nov 13 Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
    Oct 22 Positive Partial 12-Week Body Weight Results from Lexaria’s GLP-1 Diabetes Animal Study
    Oct 16 Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    Oct 16 Companies Like Lexaria Bioscience (NASDAQ:LEXX) Are In A Position To Invest In Growth
    Oct 9 Lexaria Bioscience Launches Human Study of DehydraTECH-Processed Tirzepatide
    Oct 9 Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
    Oct 8 Lexaria Updates Current GLP-1 Market
    Oct 1 Lexaria Appoints Michael Shankman as Chief Financial Officer
    Sep 27 Lexaria Bioscience Receives Approval From Independent Review Board for Pilot Study of Tirzepatide
    See more LEXX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.85
    52 Week Low 1.2
    Average Volume 118,943
    200-Day Moving Average 3.03
    50-Day Moving Average 2.77
    20-Day Moving Average 2.29
    10-Day Moving Average 2.21
    Average True Range 0.18
    RSI (14) 39.02
    ADX 23.25
    +DI 17.35
    -DI 22.02
    Chandelier Exit (Long, 3 ATRs) 2.32
    Chandelier Exit (Short, 3 ATRs) 2.50
    Upper Bollinger Bands 2.64
    Lower Bollinger Band 1.95
    Percent B (%b) 0.37
    BandWidth 30.03
    MACD Line -0.18
    MACD Signal Line -0.19
    MACD Histogram 0.0143
    Fundamentals Value
    Market Cap 23.22 Million
    Num Shares 10.6 Million
    EPS -0.84
    Price-to-Earnings (P/E) Ratio -2.62
    Price-to-Sales 85.26
    Price-to-Book 5.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.39
    Resistance 3 (R3) 2.39 2.34 2.36
    Resistance 2 (R2) 2.34 2.29 2.33 2.35
    Resistance 1 (R1) 2.27 2.26 2.30 2.26 2.34
    Pivot Point 2.21 2.21 2.23 2.21 2.21
    Support 1 (S1) 2.14 2.16 2.18 2.14 2.06
    Support 2 (S2) 2.09 2.13 2.08 2.05
    Support 3 (S3) 2.02 2.09 2.04
    Support 4 (S4) 2.01